Early Data Indicates an AI-Generated Drug Could Slow Aging
The New York Times ● Covered by 3 sources
Rentosertib, an AI-assisted drug candidate, showed early evidence that it may slow aging beyond treating chronic lung disease. It reduced biological-age markers across six aging clocks. The results mean the drug’s potential is expanding to aging, though it is still years away from regulatory approval.
Why it matters
Rentosertib—created with AI assistance—may slow the aging process, not just treat chronic lung disease. In early data it reduced biological age markers across six “aging clocks,” though it’s still years away from regulatory approval.